The present study assessed the prevalence, patterns and determinants of dyslipidaemia among South African adults with multi-morbidities. In this study, 614 individuals with DM and hypertension were recruited. Dyslipidaemia was defined as elevated levels of total cholesterol (TC) ≥ 5.2 mmol/L and/or low-density lipoprotein cholesterol (LDL-C) ≥ 2.6 mmol/L, triglycerides (TG) ≥ 1.8 mmol/L and low high-density lipoprotein cholesterol (HDL-C) < 1 mmol/L for men and < 1.2 mmol/L for women. Multivariate regression model (adjusted) analysis was used to identify the significant determinants of dyslipidaemia. The prevalence of dyslipidaemia was 76.7% (n = 471), with females showing the highest prevalence 357 (75.79%)
Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive...
AIMS:To describe the distribution and examine the associations of diabetes, hypertension and hyperch...
AimsTo describe the distribution and examine the associations of diabetes, hypertension and hypercho...
Background. The prevalence of cardiovascular disease is projected to be 38.7% for the USA in 2020, i...
Summary: Background: The burden of dyslipidaemia in Africa remains inadequately characterised. We a...
Abstract Background Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death worldwi...
The burden of dyslipidaemia is rising in many low income countries. However, there are few data on t...
Background: Non-communicable diseases, notably hypertension and diabetes mellitus have become an imp...
Background: Diabetes mellitus (DM) is a common secondary cause of dyslipidaemia, particularly if gly...
Hypercholesterolaemia is a major risk factor for coronary heart disease (CHD) especially in industri...
Background: Diabetes is a major health problem and cause of death worldwide. It is predicted that th...
BACKGROUND: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
Background: Prescribed Minimum Benefit Chronic Disease List (PMB CDL) conditions are a regulated lis...
Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive...
OBJECTIVES: This study sought to assess the burden, pattern and predictors of dyslipidaemia in 425 a...
Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive...
AIMS:To describe the distribution and examine the associations of diabetes, hypertension and hyperch...
AimsTo describe the distribution and examine the associations of diabetes, hypertension and hypercho...
Background. The prevalence of cardiovascular disease is projected to be 38.7% for the USA in 2020, i...
Summary: Background: The burden of dyslipidaemia in Africa remains inadequately characterised. We a...
Abstract Background Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death worldwi...
The burden of dyslipidaemia is rising in many low income countries. However, there are few data on t...
Background: Non-communicable diseases, notably hypertension and diabetes mellitus have become an imp...
Background: Diabetes mellitus (DM) is a common secondary cause of dyslipidaemia, particularly if gly...
Hypercholesterolaemia is a major risk factor for coronary heart disease (CHD) especially in industri...
Background: Diabetes is a major health problem and cause of death worldwide. It is predicted that th...
BACKGROUND: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
Background: Prescribed Minimum Benefit Chronic Disease List (PMB CDL) conditions are a regulated lis...
Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive...
OBJECTIVES: This study sought to assess the burden, pattern and predictors of dyslipidaemia in 425 a...
Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive...
AIMS:To describe the distribution and examine the associations of diabetes, hypertension and hyperch...
AimsTo describe the distribution and examine the associations of diabetes, hypertension and hypercho...